Successful Treatment of Multiple Plantar Warts Using Modified Saturated Saline Immersion: A Case Report [0.03%]
饱和盐水改良浸泡疗法成功治疗多发足底疣1例报告
Yechen Li,Jiayi Dong,Xinyi Dai et al.
Yechen Li et al.
Thyroid Hormone-Induced Metabolic Stress Unmasking Latent Wernicke Encephalopathy [0.03%]
甲状腺激素诱导的代谢压力诱发潜在的维生素B1缺乏性脑病
Omar Abdul-Aziz,Musa Lughmani,Ibrahim Altorok et al.
Omar Abdul-Aziz et al.
SGLT2i Use Reduces the Risk of COPD Exacerbations Compared With DPP4is in Patients With Diabetes and Concomitant COPD: A Systematic Review and Meta-Analysis [0.03%]
与DPP4抑制剂相比，SGLT2抑制剂的使用可降低糖尿病合并慢性阻塞性肺疾病患者急性加重的风险：系统评价和 meta 分析
Dua Ali,Zainab Binte Ahmad,Muhammad Waqas et al.
Dua Ali et al.
Carbamazepine-Associated Granulomatous Hepatitis in a Pediatric Patient: A Case Report [0.03%]
卡马西平相关肉芽肿性肝炎一例报告
Selcuk Teke,Yasin M Ergen,Birce I Akcay et al.
Selcuk Teke et al.
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study [0.03%]
利塞那珠单抗治疗一线生物制剂难治性克罗恩病患者的有效性和安全性：一项长期真实世界研究
Antonio Tursi,Giammarco Mocci,Franco Scaldaferri et al.
Antonio Tursi et al.
Background: Risankizumab (RZB) is an anti-interleukin 23 (anti-IL-23) approved for the treatment of Crohn disease (CD). Study question: ...
Upadacitinib for Chronic Spontaneous Urticaria: A Retrospective Study [0.03%]
_upadacitinib治疗慢性自发性荨麻疹的回顾性研究
Yu-Ting Gan,Shi Yan,Yi Liu et al.
Yu-Ting Gan et al.
Iohexol-Induced Toxic Epidermal Necrolysis: A Case Report and Review of the Literature [0.03%]
伊俄特美林致中毒性表皮坏死松解症1例并文献复习
Nour Elhouda Zouaoui,Fatma Zgolli,Asma Jerbi et al.
Nour Elhouda Zouaoui et al.
Long-Term Stroke Outcomes With Carotid Endarterectomy Versus Medical Therapy in Asymptomatic Carotid Stenosis [0.03%]
对于无症状颈动脉狭窄患者行颈动脉内膜剥脱术与药物治疗的长期脑卒中结局分析
Tallal M Hashmi,Mushood Ahmed,Hadiah Ashraf et al.
Tallal M Hashmi et al.